Dear Friends and Colleagues,
 
First and foremost, I would like to take this opportunity to thank you for your continued support.
 
2024 was a challenging year for Japan, ushered in with an earthquake in the Noto Peninsula and an aviation accident at Haneda airport. Alongside recurring natural disasters, significant political and economic fluctuations further tested society as a whole. The healthcare sector also experienced notable reforms, such as the full implementation of the “Work Style Reform for Doctors” and the transition to the My Number Health Insurance Card. Against this backdrop of a turbulent year, we published three newsletters to share insights on critical themes and foster dialogue with our readers.
 
In March, we released the newsletter titled, “Environmental Changes and Health in Medical Practice – What changes should we expect from work style reforms for doctors?” This issue delved into the impact of reforms aimed at reducing the burden on medical professionals and enhancing the quality of patient care. We received broad positive responses, reflecting the importance of understanding the challenges facing the healthcare field and building a sustainable medical system.
 
October’s newsletter, “Survey Results: Exploring Strategies for Media and Healthcare Companies in a Post-COVID Era,” presented survey results on which types and formats of information media outlets are most interested in receiving. This feature provided insights into how the role of corporate communication has evolved in the post-pandemic era and offered new perspectives on how COSMO and its clients are adapting to these changes.
 
The focus for November’s newsletter was, “Leveraging “Media Analysis” for Successful PR Strategies.” This issue explored the significance of integrating media trends into corporate PR strategies. We hope the ideas shared served as helpful hints to enhance the effectiveness of your ongoing monitoring activities.
 
Looking ahead to 2025, we are committed to further developing these initiatives, and strengthening our support for companies and organizations as they build trustful relationships with society to co-create a sustainable future. As digital transformation accelerates, the importance of accurate and empathetic communication will continue to grow. With “trust” and “empathy” as our guiding principles, we will remain flexible and agile in navigating this rapidly changing environment, creating new value together with our clients.
 
We extend our heartfelt gratitude for placing your trust in COSMO and look forward to our partnership achieving more together in 2025.
 
I wish you a happy, healthy and prosperous year ahead!

Kumi Sato
President and CEO
Cosmo Public Relations Corporation

Note: Our office will be closed for winter vacation from December 30 through January 3. We will be open for business from January 6. Thank you for your understanding and cooperation.

Dear Friends and Colleagues,
 
First and foremost, I would like to take this opportunity to thank you for your continued support.

Dear Friends and Colleagues,
 
Preparations for the post-COVID-19 era have opened up new challenges for all of us, including how to operate remotely and taking precautions, such as continuing to wear masks even in the workplace.
 
Japan is still preparing to cope with an eighth wave of COVID, although, work and life are generally back to normal.

Dear Friends and Colleagues,

This year is a special year for Cosmo Public Relations Corporation (“COSMO”). It marks our 60th anniversary. This occasion has allowed for some personal reflection on where COSMO has come from and where we would like to go in the future.

After nearly 60 years in business since it was established, COSMO reflects on the past 12 months of helping MNCs navigate Japanese healthcare communications.

Healthcare Communication Consulting

Healthcare communications consultancy has grown further into our core offering since we first committed to this space over a decade ago. This year, COSMO was a leading consulting agency for one of the largest M&A deals by a Japanese company.

We also managed product launches across varied disease areas and proactively communicated clinical milestones. COSMO provided English and Japanese communication services across preclinical to launch phases for both established pharmaceutical companies and upcoming biotech companies.